Lexie B3 vs MDHearing Neo XS

The Lexie B3 is a behind-the-ear OTC hearing aid priced at $999 that earns an A grade with a SoundScore of 4.8/5 in our lab testing. This places it at #1 among the 65 OTC hearing aids we've evaluated, making it a standout performer in its category. In our standardized testing, the Lexie B3 demonstrates excellent speech-in-quiet performance at 4.5/5, scoring 1.73 points above the OTC category average of 2.79/5. Speech-in-noise results are more nuanced—while the 2.5/5 score sits 1.02 points above the category average of 1.48/5, this remains mixed in absolute terms. Music streaming quality is solid at 3.3/5, exceeding the category average by 1.38 points, and feedback handling is excellent at 4.6/5. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above the category average. The device uses a tulip dome coupling in both initial and tuned configurations, maintaining consistent performance across fitting conditions with identical normalized scores of 4.8/5 for both fits. For those considering alternatives, devices like the RxEars Rxi, Meta Ray-Ban Glasses (Gen 2), and Cearvol Wave offer lower price points, though with correspondingly lower SoundScores. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance who prioritize speech clarity in quieter environments and quality music streaming, and who can accommodate its mid-tier OTC price point.

The MDHearing Neo XS is a budget-priced OTC hearing aid in the invisible-in-ear style, available for $397. In HearAdvisor lab testing, it earned a C grade with a SoundScore of 2.9/5, ranking #63 of 65 OTC hearing aids tested. Performance results reveal a mixed profile. The Neo XS shows strength in own-voice comfort, scoring 3.2/5—0.69 points above the category average—meaning wearers may experience less of the "boomy" quality that can accompany hearing aid use. Feedback handling is excellent at 5.0/5, sitting 0.46 points above average, so users should experience stable performance without whistling during typical wear. However, speech clarity is a significant limitation. Speech in quiet scores just 1.0/5, falling 1.77 points below the OTC category average. Speech in noise also scores 1.0/5, 0.48 points below average. Music streaming scored 0.0/5, which is 1.92 points below the category average—this device is not suited for audio entertainment. At this price point, several alternatives offer notably stronger performance. The Elehear Beyond (4.36/5), Apple AirPods Pro 2 (4.06/5), and Zepp Clarity Omni (3.88/5) all deliver better overall sound quality in the same price range. The Neo XS may appeal to those prioritizing own-voice comfort and feedback stability over speech intelligibility, but most users seeking meaningful hearing benefit should consider higher-scoring options.